ThermiPaq Hot & Cold Therapy Brand

ThermiPaq specializes in innovative hot and cold therapy solutions aimed at alleviating pain and enhancing recovery. Their products cater to individuals managing various health conditions, providing effective thermal applications for relief. ThermiPaq operates under Carex Health Brands and was established in 1990 in Springfield, US. The company acquires its focus on thermal therapy solutions through the acquisition by Carex Health Brands, a portfolio company of Ancor Capital Partners, in November 2013.

The company's founder details are not readily available. Carex Health Brands offers a wide range of health and wellness products designed to improve the quality of life for individuals managing various health conditions. Their core offerings include hot and cold therapy solutions, mobility aids, bath safety equipment, sleep therapy products, and pain management tools. The ThermiPaq Hot & Cold Pain Relief Wrap, which utilizes a unique thermal ceramic compound for effective pain relief, is among their flagship products.

These items are specifically aimed at addressing conditions such as arthritis, back pain, fibromyalgia, and muscle strain and cater to a diverse clientele, including consumers with chronic pain and healthcare professionals. Carex markets its products throughout North America through direct sales, partnerships, and retail distribution channels. Carex Health Brands operates with a diverse revenue model, which includes direct-to-consumer sales and partnerships with retailers and healthcare providers. Revenue is generated through the sale of products, including the ThermiPaq line, which facilitates pain relief through advanced thermal technology.

Customers purchase these products primarily through the Carex website or authorized retailers, often benefiting from promotional offers. The pricing is competitive to attract a wide customer base, and purchases can also be made via health savings accounts (HSA) and flexible spending accounts (FSA). Looking ahead, ThermiPaq plans to enhance its product lineup with new offerings designed to further address pain management needs, although specific details and release dates are not disclosed. The company is exploring expansion into additional North American markets to reach a broader audience.

The funding received during the acquisition will support these growth initiatives and product development efforts.